Liquid Biopsy for Prognosis and Treatment in Metastatic Colorectal Cancer: Circulating Tumor Cells vs Circulating Tumor DNA.

MLA

Patelli, Giorgio, et al. “Liquid Biopsy for Prognosis and Treatment in Metastatic Colorectal Cancer: Circulating Tumor Cells vs Circulating Tumor DNA.” Targeted Oncology, vol. 16, no. 3, May 2021, pp. 309–24. EBSCOhost, https://doi.org/10.1007/s11523-021-00795-5.

APA

Patelli, G., Vaghi, C., Tosi, F., Mauri, G., Amatu, A., Massihnia, D., Ghezzi, S., Bonazzina, E., Bencardino, K., Cerea, G., Siena, S., & Sartore-Bianchi, A. (2021). Liquid Biopsy for Prognosis and Treatment in Metastatic Colorectal Cancer: Circulating Tumor Cells vs Circulating Tumor DNA. Targeted Oncology, 16(3), 309–324. https://doi.org/10.1007/s11523-021-00795-5

Chicago

Patelli, Giorgio, Caterina Vaghi, Federica Tosi, Gianluca Mauri, Alessio Amatu, Daniela Massihnia, Silvia Ghezzi, et al. 2021. “Liquid Biopsy for Prognosis and Treatment in Metastatic Colorectal Cancer: Circulating Tumor Cells vs Circulating Tumor DNA.” Targeted Oncology 16 (3): 309–24. doi:10.1007/s11523-021-00795-5.